filmov
tv
ASCO 2024: key updates in gastric, colorectal, and hepatocellular cancer treatments
Показать описание
Ian Chau, MD, from Royal Marsden Hospital in London, UK, anticipates key presentations at ASCO 2024, particularly comparing preoperative chemoradiation to therapeutic chemotherapy in resectable gastric cancer, resolving a longstanding debate. Additionally, he looks forward to data on dual checkpoint therapy versus ipilimumab plus nivolumab in colorectal cancer and hepatocellular carcinoma, which promises insights into novel treatment approaches. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
0:00:40
0:08:19
0:14:26
0:27:17
0:29:21
0:21:25
0:14:27
0:01:00
1:36:31
1:00:51
0:01:35
0:20:35
0:07:12
0:28:28
0:02:47
0:46:14
1:03:54
0:59:35
0:11:20
0:02:40
0:20:54
0:22:08
0:03:40
0:04:14